AI drug discovery firm Insilico Medicine signs deal with Korea’s SK Biopharmaceuticals worth $2.5B
Insilico Medicine, the Hong Kong-listed AI drug discovery company, has signed a partnership with Korea’s SK Biopharmaceuticals to help develop ...
Friday, June 26, 2026
Tag: 2.5B
Factorial just raised $150M at a $2.5B valuation, but the $540M sitting next to that equity cheque is what actually signals the next phase of European software financing
Barcelona’s Factorial just closed a $150 million Series D at a $2.5 billion valuation, led by General Catalyst with participation ...
Hapoalim posts NIS 2.5b profit, declares 50% dividend
Annualized return on equity was high at 16.7%, up from 16.4% in the corresponding quarter of 2024. ...
-1024x683.jpg "Florida Roads Become a Battleground for Illegal Immigration")
The first and only national digital and print magazine that connects individuals, families, and businesses to Fee-Only financial advisers, accountants, attorneys and college guidance counselors.